Effects of GLP-1 receptor agonists on myokine levels and pro-inflammatory cytokines in patients with type 2 diabetes mellitus
The antibodies used for the immunoblot assays were: GCLC (Santa Cruz Biotech, #sc-390811), NQO1 (Sigma Prestige Antibodies, HPA007308), ACTIN (Sigma, A1978), NRF2 (Cell Signaling Technology, #12721), NRF1 (Cell Signaling Technology, #8052), YAP/TAZ (Cell Signaling, #8418) 4-HNE (Abcam, #ab46545) and Lamin A/C (Cell Signaling, #4777)
Retatrutide adds glucagon receptor activation as a third pathway, making it a triple agonist
Any source offering semaglutide without a prescription should be avoided, as it may be unsafe or counterfeit